Comanagement News

April is Sjögren’s Awareness Month, during which the Sjögren’s Syndrome Foundation along with members and volunteers seek to educate patients and families about Sjögren’s syndrome.

Researchers noted marked deterioration in visual acuity over 2 years in patients who discontinued treatment for neovascular age-related macular degeneration.

Illuma Care Connections, a new care coordination company for eye care providers and health plan partners, announced the launch of technology-enabled services that integrate eye care service into mainstream health care delivery.

ATLANTA – Peter Veldman, MD, presented a special session on corneal transplantation here at SECO, urging optometrists to learn about all surgical options to direct the patient, “who’s looking to you for guidance,” he said, to the right surgeon who will tailor the appropriate procedure to that patient’s condition.

ATLANTA – Preeya Gupta, MD, a cornea special session panelist here at SECO, said new and up-and-coming intraocular lenses are helping patients achieve refractive outcomes.

ATLANTA – Elizabeth Yeu, MD, a panelist for a SECO special session on cornea, said preoperative evaluation and care of the patient with astigmatism who is undergoing refractive cataract surgery is the best form of medicine.

ATLANTA – “Macular degeneration is the most common and maybe the most complex choroidal retinal degeneration. It started to be understood in the 1960s, but it’s not that long ago that the sequence of the development of drusen and atrophy has been understood, in part,” Eric J. Sigler, MD, a retinal specialist, said here at SECO.

ATLANTA – When referring patients for selective corneal transplantation, “It’s important for you to think about enabling your patients to see someone who offers a range of options and is able to tailor the procedure to the disease at hand,” Peter Veldman, MD, told attendees at a special session here at SECO.

ATLANTA -- Rich Mangan, OD, a Primary Care Optometry News Editorial Board member, shared clinical pearls from some of the sessions he attended at SECO.

ATLANTA – Eric Sigler, MD, focused on choroidal retinal degenerations during the Retina Roundup here at SECO. “We found that it’s an exciting time, as many treatments will be effective in the future like lampalizumab and other genetic therapies to modify the risk and progression of macular degeneration,” he said.